SCHEMBL23959309

SCHEMBL23959309

Cc1cc(C)c2c(c1)c1cc(C)cc(C)c1n2-c1ccc(-c2ccn3c(-c4ccccc4)c(-c4ccccc4)nc3n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 12/20 0.49
▸ AKT2 P31751 11/20 0.49
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ USP2 O75604 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ ATM Q13315 1/20 0.37
▸ ROCK2 O75116 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ MAPK13 O15264 3/20 0.35
▸ MAPK12 P53778 3/20 0.35
▸ MAPK11 Q15759 3/20 0.35
▸ MAPK14 Q16539 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959306 0.84 AKT1 (0.50) AKT1AKT2MEN1KMT2AUSP2
SCHEMBL23959314 0.84 AKT1 (0.43) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959299 0.82 AKT2 (0.46) AKT1AKT2
SCHEMBL23959211 0.80 AKT1 (0.50) AKT1AKT2KDM4EROCK2PIM1
SCHEMBL23959279 0.79 AKT2 (0.47) AKT1AKT2SMN1; SMN2MAPTRAB9A
SCHEMBL23959308 0.79 AKT1 (0.56) AKT1AKT2MEN1KMT2AUSP2
SCHEMBL23959116 0.79 AKT1 (0.45) AKT1AKT2
SCHEMBL23959280 0.78 AKT1 (0.53) AKT1AKT2MEN1KMT2AUSP2
SCHEMBL22905607 0.78 MEN1 (0.45) MEN1KMT2AMAPK1L3MBTL1HPGD
SCHEMBL23959107 0.78 AKT1 (0.47) AKT1AKT2MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885MEN1 301/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885MEN1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback